Steward Partners Investment Advisory, LLC Bei Gene, Ltd. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 707 shares of BGNE stock, worth $160,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
707
Previous 699
1.14%
Holding current value
$160,283
Previous $156,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BGNE
# of Institutions
251Shares Held
45.6MCall Options Held
322KPut Options Held
144K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.4 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.46 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.17 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA5.1MShares$1.16 Billion0.74% of portfolio
-
Baillie Gifford & CO3.67MShares$832 Million0.54% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...